 |
PDBsum entry 5jsf
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
5jsf
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Oxidoreductase
|
 |
|
Title:
|
 |
Crystal structure of 17beta-hydroxysteroid dehydrogenase 14 s205 variant in complex with NAD.
|
|
Structure:
|
 |
17-beta-hydroxysteroid dehydrogenase 14. Chain: a. Synonym: 17-beta-hsd 14,17-beta-hydroxysteroid dehydrogenase dhrs10, dehydrogenase/reductase sdr family member 10,retinal short-chain dehydrogenase/reductase retsdr3,short chain dehydrogenase/reductase family 47c member 1. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: hsd17b14, dhrs10, sdr3, sdr47c1, unq502/pro474. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693. Expression_system_variant: plyss
|
|
Resolution:
|
 |
|
1.84Å
|
R-factor:
|
0.166
|
R-free:
|
0.187
|
|
|
Authors:
|
 |
N.Bertoletti,S.Marchais-Oberwinkler,A.Heine,G.Klebe
|
|
Key ref:
|
 |
N.Bertoletti
et al.
(2016).
New Insights into Human 17β-Hydroxysteroid Dehydrogenase Type 14: First Crystal Structures in Complex with a Steroidal Ligand and with a Potent Nonsteroidal Inhibitor.
J Med Chem,
59,
6961-6967.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
08-May-16
|
Release date:
|
13-Jul-16
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q9BPX1
(DHB14_HUMAN) -
17-beta-hydroxysteroid dehydrogenase 14 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
270 a.a.
268 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.1.1.1.62
- 17beta-estradiol 17-dehydrogenase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
17beta-estradiol + NAD+ = estrone + NADH + H+
|
|
2.
|
17beta-estradiol + NADP+ = estrone + NADPH + H+
|
|
 |
 |
 |
 |
 |
17beta-estradiol
|
+
|
NAD(+)
Bound ligand (Het Group name = )
corresponds exactly
|
=
|
estrone
|
+
|
NADH
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
17beta-estradiol
|
+
|
NADP(+)
Bound ligand (Het Group name = )
matches with 91.67% similarity
|
=
|
estrone
|
+
|
NADPH
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Med Chem
59:6961-6967
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
New Insights into Human 17β-Hydroxysteroid Dehydrogenase Type 14: First Crystal Structures in Complex with a Steroidal Ligand and with a Potent Nonsteroidal Inhibitor.
|
|
N.Bertoletti,
F.Braun,
M.Lepage,
G.Möller,
J.Adamski,
A.Heine,
G.Klebe,
S.Marchais-Oberwinkler.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
17β-HSD14 is a SDR enzyme able to oxidize estradiol and 5-androstenediol using
NAD(+). We determined the crystal structure of this human enzyme as the holo
form and as ternary complexes with estrone and with the first potent,
nonsteroidal inhibitor. The structures reveal a conical, rather large and
lipophilic binding site and are the starting point for structure-based inhibitor
design. The two natural variants (S205 and T205) were characterized and adopt a
similar structure.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |